Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$133.07

5.35 (4.19%)

, TMO

Thermo Fisher

$171.93

0.19 (0.11%)

10:23
05/19/17
05/19
10:23
05/19/17
10:23

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Bernstein initiated Nvidia (NVDA) with an Outperform and a $165 price target. 2. Cantor Fitzgerald initiated Thermo Fisher (TMO) with an Overweight rating and $194 price target. 3. Pacific Crest initiated IBM (IBM) with a Sector Weight rating. 4. Conduent (CNDT) initiated with a Market Perform rating and $18 price target at Cowen. 5. JMP Securities started coverage of Spring Bank Pharmaceuticals (SBPH) with a $20 price target and an Outperform rating. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NVDA

Nvidia

$133.07

5.35 (4.19%)

TMO

Thermo Fisher

$171.93

0.19 (0.11%)

IBM

IBM

$151.90

1.12 (0.74%)

CNDT

Conduent

$16.90

0.2 (1.20%)

SBPH

Spring Bank Pharmaceuticals

$11.81

-0.19 (-1.58%)

  • 23

    May

  • 06

    Jun

  • 09

    Jun

NVDA Nvidia
$133.07

5.35 (4.19%)

05/19/17
BERN
05/19/17
INITIATION
BERN
Outperform
Nvidia initiated at Bernstein
As noted earlier, Bernstein started coverage of Nvidia with a $165 price target and an Outperform rating. The analyst thinks that the stock can rise further, driven by a large datacenter total available market, significant automotive growth, and sustainable gaming growth.
05/18/17
BERN
05/18/17
INITIATION
Target $165
BERN
Outperform
Nvidia initiated with an Outperform at Bernstein
Bernstein initiated Nvidia with an Outperform and a $165 price target.
05/15/17
GSCO
05/15/17
NO CHANGE
Target $165
GSCO
Conviction Buy
Nvidia price target raised to $165 from $130 at Goldman Sachs
Goldman Sachs analyst Toshiya Hari said hte market continues to under-appreciate Nvidia's Datacenter long-term growth opportunity. Hari was surprised by last week's launch of Volta and the associated improvement in performance and sees meaningful upside to Street estimates for FY18/19. The analyst remains positive on Nvidia's positioning in AI/ML inference market and 2020 TAM forecasts provided by the company and reiterates his Coviction Buy rating.
05/12/17
RBCM
05/12/17
NO CHANGE
RBCM
Nvidia price target raised to $150 from $138 at RBC Capital
After attending Nvidia's Analyst Day, RBC Capital analyst Mitch Steves raised his price target on Nvidia. The analyst thinks that the company's high margin data center revenue should grow by triple digit percentage levels and he estimates that its artificial intelligence revenue is increasing "more than 200%." He keeps an Outperform rating on the stock.
TMO Thermo Fisher
$171.93

0.19 (0.11%)

05/18/17
CANT
05/18/17
INITIATION
Target $194
CANT
Overweight
Thermo Fisher initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Bryan Brokmeier initiated Thermo Fisher with an Overweight rating, as he sees significant opportunity for organic growth and for M&A. He set a $194 price target on Thermo Fisher, which he calls a "key beneficiary" of continued strength in biopharma.
05/16/17
JEFF
05/16/17
DOWNGRADE
Target $35
JEFF
Hold
Patheon downgraded to Hold from Buy at Jefferies
Jefferies analyst David Windley downgraded Patheon (PTHN) to Hold saying he sees little risk to the Thermo Fisher (TMO) takeover deal ultimately closing by year-end 2017. The believes the offer fairly values Patheon. The analyst raised his price target for the shares to $35 from $32.
05/15/17
PIPR
05/15/17
DOWNGRADE
Target $35
PIPR
Neutral
Patheon downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Sean Wieland downgraded Patheon (PTHN) to Neutral from Overweight and raised his price target to $35 from $33 to reflect the company's agreement to be acquired by Thermo Fisher (TMO). In his downgrade note, Wieland added that Catalent (CTLT) is comparable to Patheon and would trade at $36 if the same valuation as used in Thermo Fisher's deal is applied.
05/09/17
BOFA
05/09/17
NO CHANGE
Target $200
BOFA
Buy
Thermo Fisher added to US 1 List at BofA/Merrill
BofA/Merrill analyst Derik de Bruin added Thermo Fisher to the US 1 List following the better-than-expected Q1 report and increased its price target to $200 from $190. The analyst said Thermo is one of the best positioned life science tools companies with strong execution, improving comps ahead, and a potential end market rebound.
IBM IBM
$151.90

1.12 (0.74%)

05/16/17
MSCO
05/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM at attractive entry point ahead of mainframe cycle, says Morgan Stanley
Morgan Stanley analyst Katy Huberty attributes recent weakness in shares of IBM (IBM) to the combination of the news that Warren Buffett's Berkshire Hathaway (BRK.A) cut its stake by a third and the company's weak Q1 gross margin trends. However, growth accelerates and margins expand historically for IBM around a mainframe cycle, making the pullback an attractive entry point, according to Huberty. The analyst, who sees a number of the gross margin pressures that have recently plagued IBM abating in the second half of 2017, has a $212 price target on Big Blue's shares.
05/08/17
BERN
05/08/17
NO CHANGE
BERN
IBM shouldnt be bought on weakness, says Bernstein
Bernstein analyst A.M. (Toni) Sacconaghi, Jr.does not recommend buying IBM on weakness. The analyst says that the success of the company's turnaround efforts is "uncertain," while the stock is still expensive. The analyst keeps a Market Perform rating.
04/20/17
ARGS
04/20/17
NO CHANGE
ARGS
IBM a value play that's 'becoming a growth story,' says Argus
After IBM reported lower than expected revenue and what Argus analyst Jim Kelleher sees as "weak" gross margins, the analyst says that the stock remains a value play, given its decline from its peak prices above $215. However, the analyst thinks that the company is on the path to becoming a unique cloud and cognitive paltform" and is transitioning to "a growth story." The analyst is upbeat on the company's Watson solution and keeps a $192 price target and a Buy rating on the stock.
05/18/17
PACS
05/18/17
INITIATION
PACS
Sector Weight
IBM initiated with a Sector Weight at Pacific Crest
CNDT Conduent
$16.90

0.2 (1.20%)

02/23/17
SBSH
02/23/17
NO CHANGE
Target $17
SBSH
Buy
Citi says buy Conduent despite 'real mess' of a quarter
Citi analyst Jim Suva says Conduent is not "structurally flawed" following its "real mess" of a quarter. Much of the company's issues will be cleaned up over the next year as unprofitable contracts come off the books and charges end, Suva tells investors. He recommends buying the shares with a Buy rating and $17 price target.
01/10/17
GSCO
01/10/17
UPGRADE
Target $8.5
GSCO
Buy
Xerox upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Matthew Cabral upgraded Xerox (XRX) to Buy saying the spin-off of the company's Business Process Outsourcing businesses into Conduent (CNDT) is a "major catalyst." The move should produce greater than $1.5B in savings through 2018 and allow for targeted investments in "pockets of growth," Cabral tells investors in a research note. He lowered his price target for Xerox to $8.50 from $10.50.
05/19/17
COWN
05/19/17
INITIATION
Target $18
COWN
Market Perform
Conduent initiated with a Market Perform at Cowen
Cowen analyst Bryan Bergin initiated Conduent with a Market Perform and an $18 price target saying topline visibility is a key unknown and prefers to wait for evidence on execution.
01/26/17
SBSH
01/26/17
INITIATION
Target $17
SBSH
Buy
Conduent initiated with a Buy at Citi
Citi analyst Jim Suva started Conduent (CDNT) with a Buy rating and $17 price target. The analyst expects the Xerox (XRX) spinoff to unlock value through cost reductions and an improved focus. He also raised his price target for Xerox shares to $9 from $7.90 and keeps a Buy rating on the name.
SBPH Spring Bank Pharmaceuticals
$11.81

-0.19 (-1.58%)

08/19/16
WBLR
08/19/16
INITIATION
Target $26
WBLR
Outperform
Spring Bank Pharmaceuticals initiated with an Outperform at William Blair
William Blair analyst Y. Katherine Xu started Spring Bank Pharmaceuticals with an Outperform rating and $26 price target.
03/03/17
WBLR
03/03/17
NO CHANGE
WBLR
HBV space to consolidate over next five years, says William Blair
William Blair analyst Y. Katherine Xu sees curing chronic hepatitis B virus infections as "the next frontier" after the success of hepatitis C treatments and believes the market for an HBV cure could be "similar in size to that of HCV," or $200B in cumulative global sales over a span of two decades. She expects consolidation of the HBV market over the next five years, much like what happened with the HCV market. Xu sees Spring Bank Pharmaceuticals (SBPH) and Arbutus (ABUS) as having the strongest data catalysts in 2017, followed by Assembly Biosciences (ASMB) and Arrowhead (ARWR). She has Outperform ratings on the first three stocks and a Market Perform rating on Arrowhead.
05/02/17
CHDN
05/02/17
INITIATION
Target $16.5
CHDN
Buy
Spring Bank Pharmaceuticals initiated with a Buy at Chardan
Chardan analyst Madhu Kumar initiated Spring Bank Pharmaceuticals with a Buy and a $16.50 price target.
05/19/17
JMPS
05/19/17
INITIATION
JMPS
Outperform
Spring Bank Pharmaceuticals initiated with an Outperform at JMP Securities
JMP Securities analyst Liisa Bayko started coverage of Spring Bank with a $20 price target and an Outperform rating. She says that Spring Bank's SB9 9200 drug could become "a backbone of HBV therapy," creating a multibillion dollar revenue stream for the company.

TODAY'S FREE FLY STORIES

BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

10:47
07/25/17
07/25
10:47
07/25/17
10:47
Initiation
Blue Buffalo Pet Products initiated  »

Blue Buffalo Pet Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

, GOOG

Alphabet

$980.34

7.42 (0.76%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Hot Stocks
Analysts stay bullish on Alphabet after earnings with growth seen continuing »

Shares of Google's…

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

GOOG

Alphabet

$980.34

7.42 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.09

0.27 (0.75%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Hot Stocks
Breaking Hot Stocks news story on General Motors »

General Motors says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

VRX

Valeant

$17.97

0.43 (2.45%)

10:45
07/25/17
07/25
10:45
07/25/17
10:45
Options
Valeant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 24

    Aug

10:45
07/25/17
07/25
10:45
07/25/17
10:45
General news
Treasury 2-year auction outlook: »

Treasury 2-year auction…

CIT

CIT Group

$48.74

-0.16 (-0.33%)

10:38
07/25/17
07/25
10:38
07/25/17
10:38
Recommendations
CIT Group analyst commentary  »

CIT Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SRPT

Sarepta

$43.95

0.54 (1.24%)

, BIIB

Biogen

$284.70

1.78 (0.63%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Periodicals
STAT's Feuerstein puts Sarepta on list of potential targets for Biogen 

Reference Link

SRPT

Sarepta

$43.95

0.54 (1.24%)

BIIB

Biogen

$284.70

1.78 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 25

    Jul

GM

General Motors

$36.10

0.28 (0.78%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Hot Stocks
General Motors expects Q3 to be weakest quarter of the year 

Sees recovery in Q4.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue plans to update the market at year-end with its fleet review »

Comments provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue achieved $45M of $250M-$300M cost savings expected by FY20 »

JetBlue sees FY17-FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

LLY

Eli Lilly

$82.04

-2.6978 (-3.18%)

10:33
07/25/17
07/25
10:33
07/25/17
10:33
Hot Stocks
Eli Lilly sees drug pricing executive order in second half of 2017 »

Eli Lilly CEO David Ricks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

POWI

Power Integrations

$81.75

0.2 (0.25%)

, AAPL

Apple

$152.09

1.82 (1.21%)

10:32
07/25/17
07/25
10:32
07/25/17
10:32
Hot Stocks
Power Integrations cut to hold after Apple speculation fuels run-up »

The shares of Power…

POWI

Power Integrations

$81.75

0.2 (0.25%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

TSLA

Tesla

$342.52

14.12 (4.30%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Hot Stocks
Tesla Model S 'tops Consumer Reports' ratings' after adding AEB, CR says »

After updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

APRN

Blue Apron

$7.49

0.08 (1.08%)

, BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

APRN

Blue Apron

$7.49

0.08 (1.08%)

BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

ELF

e.l.f. Beauty

$26.61

1.21 (4.76%)

GWW

Grainger

$167.84

0.96 (0.58%)

WMC

Western Asset Mortgage

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Aug

  • 10

    Aug

  • 17

    Oct

  • 24

    Jan

UA

Under Armour

$18.21

-0.0485 (-0.27%)

, UAA

Under Armour

$20.29

0.02 (0.10%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

UA

Under Armour

$18.21

-0.0485 (-0.27%)

UAA

Under Armour

$20.29

0.02 (0.10%)

SNAP

Snap

$13.73

-0.355 (-2.52%)

CYTX

Cytori Therapeutics

$0.48

-0.6301 (-56.77%)

LULU

lululemon

$62.02

0.08 (0.13%)

POWI

Power Integrations

$81.75

0.2 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 10

    Aug

  • 13

    Sep

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

, BIG

Big Lots

$49.66

2.1 (4.42%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

BIG

Big Lots

$49.66

2.1 (4.42%)

WERN

Werner

$29.20

-0.35 (-1.18%)

TEAM

Atlassian

$36.41

0.66 (1.85%)

DSW

DSW

$17.35

0.87 (5.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Aug

  • 08

    Aug

  • 21

    Aug

  • 25

    Sep

WBA

Walgreens Boots Alliance

$79.60

0.7 (0.89%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Hot Stocks
Walgreens to bring nearly 500 jobs to Chandler, Arizona »

Walgreens announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

FCX

Freeport McMoRan

$14.38

1.415 (10.92%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Options
Freeport McMoran options active after earnings »

Freeport McMoran options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:30
07/25/17
07/25
10:30
07/25/17
10:30
General news
Treasury Action: yields resumed their rise »

Treasury Action: yields…

SVU

Supervalu

$3.56

0.305 (9.38%)

10:28
07/25/17
07/25
10:28
07/25/17
10:28
Hot Stocks
Supervalu says FY18 base adjusted EBITDA view same ex-Unified contibution »

Sees adjusted EBITDA with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GM

General Motors

$35.90

0.0845 (0.24%)

10:27
07/25/17
07/25
10:27
07/25/17
10:27
Hot Stocks
Breaking Hot Stocks news story on General Motors »

GM CFO says 'very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:25
07/25/17
07/25
10:25
07/25/17
10:25
General news
U.S. Richmond Fed manufacturing index rose 3 points to 14 in July »

U.S. Richmond Fed…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

, CZR

Caesars

$12.90

0.2 (1.57%)

10:25
07/25/17
07/25
10:25
07/25/17
10:25
Conference/Events
Caesars to host special shareholder meeting »

Special Shareholder…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

CZR

Caesars

$12.90

0.2 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

SVU

Supervalu

$3.56

0.31 (9.54%)

, AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

10:24
07/25/17
07/25
10:24
07/25/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Supervalu, Amazon.com, Whole Foods »

Supervalu sees retail…

SVU

Supervalu

$3.56

0.31 (9.54%)

AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

WFM

Whole Foods

$41.67

-0.04 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

FCX

Freeport McMoRan

$14.28

1.315 (10.15%)

10:22
07/25/17
07/25
10:22
07/25/17
10:22
Hot Stocks
Freeport McMoRan sees 2018 consolidated copper sales of 3.85B pounds »

Freeport sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.